Clinical Trials List
Protocol NumberTMB-121
2013-02-01 - 2017-03-06
Phase I/II
Terminated3
-
Trial Applicant
PROTECH PHARMASERVICES CORPORATION
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 吳冠陞 Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 黃俊凱 Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 林德宇 Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Completed
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
47 participants
-
Global
47 participants
